Improvement Of Antitumor Activity Of Doxorubicin By Coformulation Of Crocetin And Doxorubicin In PLGANanoparticles
محل انتشار: دومین سمپوزیوم بین المللی سرطان نسترن
سال انتشار: 1395
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 484
نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
NASTARANCANSER02_231
تاریخ نمایه سازی: 22 دی 1396
چکیده مقاله:
The current study reports investigation of codelivery by PLGA nanoparticles (NPs) loaded withcrocetin (Cro), a natural carotenoid acid that is found in the crocus flower, and Doxorubicin (DOX).Double emulsion/solvent evaporation method was used for preparation of PLGA nanoparticlescontaining Dox and Cro. Characterizations of prepared NPs were investigated by atomic forcemicroscopy (AFM) and dynamic light scattering analysis. In vitro Cytotoxicity of DOX and Cro loadedPLGA NPs (PLGA-DOX-Cro) on MCF-7 cell line was evaluated using MTT test. Flow cytometryexperiments were implemented to distinguish cells undergoing apoptosis from those undergoingnecrosis. Furthermore the expression of caspase 3 was examined by western blot analysis. Results:The prepared formulations had size of 150- 300 nm. Furthermore, PLGA-DOX-Cro nanoparticlesinhibited MCF-7 tumor cells growth more efficiently than either DOX or Cro alone at the sameconcentrations, as quantified by MTT assay and flow cytometry. Studies on cellular uptake of DOXCro-NPs demonstrated that NPs were effectively taken up by MCF-7 tumor cells. This studysuggested that DOX-Cro-NPs may have promising applications in breast cancer therapy.
نویسندگان
Maryam Hashemi
Nanotechnology Research Center, School Of Pharmacy, Mashhad University Of Medical Sciences, Mashhad,Iran